Biorce funding news – Barcelona-based Biorce has Raised €3.5 Million in Funding

Invetsor of the round

The funding round was led by YZR Capital and Mustard Seed Maze, with support from Outsized Ventures, Pathena Family Office, and Plug and Play Tech Center. The money will help improve Biorce’s AI platform, particularly Jarvis, which provides real-time, cross-referenced data for patients, doctors, and researchers during clinical trials.

Read also - Oriole Networks funding news – London-based Oriole Networks Secures an Additional €20.2 Million Funding

Jarvis collects data from different sources into one place, making it easier for stakeholders to access important information quickly and reducing the need for manual checks.

Markus Feuerecker, Founding Partner at YZR Capital, commented: “Biorce’s approach to integrating AI in clinical trials promises to bridge significant gaps in the industry. They built a cutting-edge product promising significant efficiency gains for their customers. We are excited to back the team behind Pedro, Clara, José, and Diogo, whose combined experience in CROs, clinical trials management, and programming gave them the required background to work on technologies that can redefine how we think about drug development.”

Sofia Queiroz, Principal at Mustard Seed Maze, stated: “Investing in Biorce aligns perfectly with our mission to back transformative solutions in healthcare. The clinical trial landscape is ripe for disruption, and Biorce’s end-to-end AI platform has the potential to dramatically reduce the time and cost it takes to bring life-saving drugs to patients by improving the protocol and feasibility phase of clinical trials. What particularly excites us is their unique approach to building network effects through private data partnerships across the entire clinical trial ecosystem.”

Utilisation of fund

With the new investment, Biorce plans to improve clinical trial efficiency and help bring new treatments to patients faster.

Pedro Coelho said, “Clinical trials are crucial for drug development but remain hindered by inefficiencies data fragmentation, and complex logistical challenges. We’re transforming this landscape through our multi-modality platform and Jarvis, our proprietary AI model, making trials faster, more efficient, and accessible to all,”.

About Biorce

Biorce is an innovative medtech company focused on changing drug development with artificial intelligence (AI). They are committed to speeding up medical progress and improving patient outcomes.